Developer docs
API playgroundTry for free, no card

Search company profiles

Quadram Institute

Full company profile

uuid0002u2z

Namestring
Quadram Institute
Legal namestring
Quadram Institute Bioscience
Websiteurl
quadram.ac.uk
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Quadram Institute Bioscience (QIB) is a UK interdisciplinary research institute located at Norwich Research Park, founded in 2017 and operating from a state-of-the-art facility that houses fundamental and applied bioscientists alongside Europe's largest endoscopy unit. The institute investigates how food and microbes interact to promote health, with core research areas spanning gut microbiome science, food innovation, antimicrobial resistance, and infectious-disease surveillance. It maintains proprietary technical capabilities including next-generation sequencing (short- and long-read) through its QIB Extra service, advanced microscopy, gastrointestinal simulation models (colon model facility), organ-on-chip systems (including gut-brain axis models), clinical research facilities for human dietary studies, and a stack of custom bioinformatics pipelines (MATAFILER, LotuS, sdm) developed for metagenomics and bacterial strain tracking.

Quadram is funded primarily through UK public research bodies — Biotechnology and Biological Sciences Research Council (BBSRC), UK Research and Innovation (UKRI), National Institute for Health and Care Research (NIHR), and the Food Standards Agency (FSA) — with operational partnerships anchored by Norfolk and Norwich University Hospital NHS Foundation Trust, the University of East Anglia, the Earlham Institute, the John Innes Centre, and the Wellcome Sanger Institute (via the COG-UK genomics consortium). Revenue is largely grant-driven (research services, public funding), supplemented by fee-for-service sequencing and consultancy through QIB Extra, industry advisory-panel engagements, and licensing/spinout pathways (e.g., Beneforte broccoli, Xampla microencapsulation partnership, vitamin D-biofortified tomatoes). The institute's customer base spans NHS hospital trusts, UK government regulators, academic collaborators globally, and a growing set of industry partners; healthy volunteers are recruited regionally for human studies via an online participant database.

Short descriptiontext

Quadram Institute is a UK publicly-funded bioscience institute at Norwich Research Park that researches food-microbe-gut health interactions, offering sequencing, clinical, and bioinformatics services to NHS, government, academic, and industry partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNorwich, United Kingdom
HQ citystring
Norwich
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
gut microbiome research, food safety science, clinical nutrition studies, microbial genomics sequencing, bioscience research services
NAICS code4 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Bioscience Research Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Research Grants and Public Funding
TypeManaged Services
Description

The institute receives substantial funding from government bodies including UK Research and Innovation (UKRI), Biotechnology and Biological Sciences Research Council (BBSRC), National Institute for Health and Care Research (NIHR), Food Standards Agency (FSA), and other public funding bodies for fundamental and applied research programs.

quadram.ac.uk
2Fee-for-Service Sequencing and Research Services
TypeProfessional Services
Description

The institute offers commercial sequencing services through QIB Extra, providing next-generation sequencing services and consultancy on a fee-for-service basis to external researchers and organizations.

quadram.ac.uk
3Enterprise Partnerships and Spinouts
TypeLicensing Royalties
Description

The institute engages with industry through partnerships, industry advisory panels, and has created spinout companies from its research outputs.

quadram.ac.uk
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Quadram Institute Bioscience (QIB) is an interdisciplinary research institute at Norwich Research Park that investigates how food and microbes interact to promote health. It delivers fundamental and applied bioscience research spanning gut microbiome science, food safety, and clinical nutrition, supported by next-generation sequencing services, advanced microscopy, organ-on-chip and gastrointestinal simulation platforms, and an integrated Clinical Research Facility operated with Norfolk and Norwich University Hospital.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 4,644 scientific publications generated to date
+3 more records
Product overview1 text field

The Quadram Institute operates as a research institute rather than a commercial product company, offering a portfolio of research services and scientific capabilities. Core offerings include: a Clinical Research Facility for human dietary and nutrition studies; Next Generation Sequencing services for short-read and long-read DNA sequencing; the Food Safety Research Network for collaborative food safety research; and an Early Career Fellowships Programme for scientist development. Research activities focus on gut microbiome interactions, food and health, antimicrobial resistance, and microbial genomics. The institute also develops bioinformatics tools and pipelines for microbiome analysis, and has produced biofortified food products such as vitamin D tomatoes through genetic research programmes.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership20 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on UK-wide genomics study conducted by UK Food Standards Agency to investigate antimicrobial resistance in Campylobacter isolates from human infections. The study found increasing fluoroquinolone and tetracycline resistance in Campylobacter.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on UK Food Standards Agency genomics study on Campylobacter and antimicrobial resistance in food safety research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Operational partnership for the Clinical Research Facility within the Quadram Institute. Since September 2022, the CRF has become part of Norfolk CRF partly funded by NIHR. The partnership enables experimental medicine and translational research into food and nutrition.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Key academic partner on the Norwich Research Park. UEA provides student supervision, PhD programs through the NRP Doctoral Training Programme, and joint research collaborations including with the Norfolk and Norwich University Hospital on prostate cancer and other studies.

5COVID-19 Genomics UK (COG-UK) Consortium
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Led by the Wellcome Sanger Institute, this national consortium brings together NHS organisations, four Public Health Agencies, Wellcome Sanger Institute and 16+ academic institutions including Quadram Institute providing sequencing and analysis capacity for pathogen genomics.

quadram.ac.uk
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with John Innes Centre, Earlham Institute, and other bioscience organizations on the Norwich Research Park enabling shared infrastructure, NMR facilities, and interdisciplinary research collaboration.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative research on gut microbiome, microbial interactions, and bioinformatics. Prof. Falk Hildebrand holds a joint position. Shared NMR resources available at John Innes Centre and UEA.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Academic partner in the Food, Microbiome and Health research program focusing on food and gut microbiome research.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Academic partner in the Food, Microbiome and Health research program.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with NHS through Norfolk and Norwich University Hospital for clinical research and patient care innovation. NIHR Clinical Research Facility provides infrastructure.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Key strategic partner in public health research, food safety, and infectious disease surveillance through COG-UK consortium.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Collaboration with SKAN Research Trust (India) in gut microbiome research to advance understanding of microbiome-related health conditions.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

BBSRC-funded UK-China joint centre for research on probiotics. Prof. Arjan Narbad serves as Visiting Professor at Jiangnan University.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Lead institution of COG-UK consortium. Provides sequencing capacity and coordination for the national COVID-19 genomic surveillance effort.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration on Seychelles warbler research studying gut bacteria and immune system interactions, alongside UEA, Centre for Microbial Interactions, and University of Groningen.

16Cloud Infrastructure for Microbial Bioinformatics (CLIMB)
Strategic tierCoreTypeTechnology or Integration
Description

CLIMB provides cloud computing infrastructure for microbial genomics, which was leveraged for COG-UK activities. Collaboration between Warwick, Birmingham, Cardiff, Swansea, Bath, Leicester, MRC Gambia, and Quadram Institute.

quadram.ac.uk
Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

European-funded multidisciplinary training network for bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis. Prof. Nathalie Juge participates in this initiative.

18European Research Network Train2Target
Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

European Commission International Training Network funded by Horizon 2020 supporting research on Fusobacterium nucleatum and colorectal cancer.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Collaboration to advance probiotic microencapsulation technology for improved delivery of beneficial bacteria.

Strategic tierSecondaryTypeChannel Partner/ Reseller/ Distributor
Description

Structured engagement mechanism with industry partners providing guidance on research priorities and facilitating knowledge transfer from academia to commercial applications.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-based genomics and bioinformatics research institute that leads the COG-UK consortium in which Quadram participates. Operates at much larger scale but pursues overlapping pathogen genomics, microbiome, and translational biology programmes on a non-commercial, grant-funded basis.

TypeDirect peer
Description

Co-located on Norwich Research Park with Quadram; conducts plant science, microbiology, and food-related bioscience research. Directly comparable as a BBSRC-funded UK research institute with a similar funding mix and translational science mandate.

TypeDirect peer
Description

Co-located on Norwich Research Park; focused on computational bioscience, bioinformatics, and genomics. Several Quadram PIs (e.g. Falk Hildebrand) hold joint appointments, and the institute shares NMR and sequencing infrastructure with Quadram, making it a direct operating peer.

TypeDirect peer
Description

Long-standing UK agricultural and food-safety research institute also funded by BBSRC. Comparable in operating model (publicly funded research, spinout track record) and overlapping research themes in food safety, crop science, and precision breeding, including the first gene-edited barley to receive a Precision Bred Organism marketing notice.

TypeBroad incumbent
Description

Largest biomedical research institute in Europe, with overlapping interests in disease biology and translational medicine. Operates a similar model of public/charitable funding with deep clinical research partnerships, but at materially greater scale and broader scope than Quadram.

TypeDirect peer
Description

BBSRC-funded UK research institute focused on epigenetics, signalling, and immunology. Directly comparable in scale, funding mix, and biotech-spinout posture, and competes with Quadram for BBSRC strategic funding and life-science talent.

TypeDirect peer
Description

Ireland-based SFI-funded research centre focused on gut microbiome, host-microbe interactions, and microbial therapies. Closest international peer in terms of research focus (gut microbiome, microbially-produced bioactives, clinical translation), though funded through Irish research council mechanisms.

TypeBroad incumbent
Description

MRC-funded research institute in Cambridge with a track record of basic biological discovery and successful spinouts. Comparable operating model (publicly funded research with strong IP translation) but a broader life-sciences remit and a longer-established entrepreneurial pipeline.

TypeBroad incumbent
Description

European Bioinformatics Institute, part of EMBL. Comparable to Quadram's bioinformatics group (Hildebrand) in providing public-good computational infrastructure for genomics and microbiome data, including CLIMB compute used in COG-UK work that Quadram relies on.

TypeRegional player
Description

Ireland's national food and agriculture research authority, conducting food safety, microbiome, and agrifood research with similar translational and industry-facing remit to Quadram, but operating in a different national funding ecosystem.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Quadram Institute

Bioscience Research Servicesquadram.ac.uk

Quadram Institute is a UK publicly-funded bioscience institute at Norwich Research Park that researches food-microbe-gut health interactions, offering sequencing, clinical, and bioinformatics services to NHS, government, academic, and industry partners.

What Quadram Institute does

Quadram Institute Bioscience (QIB) is a UK interdisciplinary research institute located at Norwich Research Park, founded in 2017 and operating from a state-of-the-art facility that houses fundamental and applied bioscientists alongside Europe's largest endoscopy unit. The institute investigates how food and microbes interact to promote health, with core research areas spanning gut microbiome science, food innovation, antimicrobial resistance, and infectious-disease surveillance. It maintains proprietary technical capabilities including next-generation sequencing (short- and long-read) through its QIB Extra service, advanced microscopy, gastrointestinal simulation models (colon model facility), organ-on-chip systems (including gut-brain axis models), clinical research facilities for human dietary studies, and a stack of custom bioinformatics pipelines (MATAFILER, LotuS, sdm) developed for metagenomics and bacterial strain tracking.

Quadram is funded primarily through UK public research bodies — Biotechnology and Biological Sciences Research Council (BBSRC), UK Research and Innovation (UKRI), National Institute for Health and Care Research (NIHR), and the Food Standards Agency (FSA) — with operational partnerships anchored by Norfolk and Norwich University Hospital NHS Foundation Trust, the University of East Anglia, the Earlham Institute, the John Innes Centre, and the Wellcome Sanger Institute (via the COG-UK genomics consortium). Revenue is largely grant-driven (research services, public funding), supplemented by fee-for-service sequencing and consultancy through QIB Extra, industry advisory-panel engagements, and licensing/spinout pathways (e.g., Beneforte broccoli, Xampla microencapsulation partnership, vitamin D-biofortified tomatoes). The institute's customer base spans NHS hospital trusts, UK government regulators, academic collaborators globally, and a growing set of industry partners; healthy volunteers are recruited regionally for human studies via an online participant database.

Quadram Institute firmographics

Firmographics
Name
Quadram Institute
Legal name
Quadram Institute Bioscience
Website
https://quadram.ac.uk
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
101–250 employees
Short description
Quadram Institute is a UK publicly-funded bioscience institute at Norwich Research Park that researches food-microbe-gut health interactions, offering sequencing, clinical, and bioinformatics services to NHS, government, academic, and industry partners.
Ownership category
akta.pro rank

Where Quadram Institute is headquartered

Location

Headquarters

HQ city
Norwich
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Quadram Institute business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Research Grants and Public Funding: The institute receives substantial funding from government bodies including UK Research and Innovation (UKRI), Biotechnology and Biological Sciences Research Council (BBSRC), National Institute for Health and Care Research (NIHR), Food Standards Agency (FSA), and other public funding bodies for fundamental and applied research programs.
  2. Fee-for-Service Sequencing and Research Services: The institute offers commercial sequencing services through QIB Extra, providing next-generation sequencing services and consultancy on a fee-for-service basis to external researchers and organizations.
  3. Enterprise Partnerships and Spinouts: The institute engages with industry through partnerships, industry advisory panels, and has created spinout companies from its research outputs.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Quadram Institute product offering

Product offering

Core offering

The Quadram Institute Bioscience (QIB) is an interdisciplinary research institute at Norwich Research Park that investigates how food and microbes interact to promote health. It delivers fundamental and applied bioscience research spanning gut microbiome science, food safety, and clinical nutrition, supported by next-generation sequencing services, advanced microscopy, organ-on-chip and gastrointestinal simulation platforms, and an integrated Clinical Research Facility operated with Norfolk and Norwich University Hospital.

Product overview

The Quadram Institute operates as a research institute rather than a commercial product company, offering a portfolio of research services and scientific capabilities. Core offerings include: a Clinical Research Facility for human dietary and nutrition studies; Next Generation Sequencing services for short-read and long-read DNA sequencing; the Food Safety Research Network for collaborative food safety research; and an Early Career Fellowships Programme for scientist development. Research activities focus on gut microbiome interactions, food and health, antimicrobial resistance, and microbial genomics. The institute also develops bioinformatics tools and pipelines for microbiome analysis, and has produced biofortified food products such as vitamin D tomatoes through genetic research programmes.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Over 4,644 scientific publications generated to date
  • +3 more outcomes

Companies that use Quadram Institute

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Quadram Institute technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature8 records

Quadram Institute partnerships and signals

Strategic signal

Partnerships

20 partnerships are on record, tiered core, secondary and minor.

  • University of OxfordcoreStrategic or Co-development PartnerCollaboration on UK-wide genomics study conducted by UK Food Standards Agency to investigate antimicrobial resistance in Campylobacter isolates from human infections. The study found increasing fluoroquinolone and tetracycline resistance in Campylobacter.
  • Moredun InstitutecoreStrategic or Co-development PartnerCollaboration on UK Food Standards Agency genomics study on Campylobacter and antimicrobial resistance in food safety research.
  • Norfolk and Norwich University Hospital NHS Foundation TrustcoreStrategic or Co-development PartnerOperational partnership for the Clinical Research Facility within the Quadram Institute. Since September 2022, the CRF has become part of Norfolk CRF partly funded by NIHR. The partnership enables experimental medicine and translational research into food and nutrition.
  • University of East AngliacoreStrategic or Co-development PartnerKey academic partner on the Norwich Research Park. UEA provides student supervision, PhD programs through the NRP Doctoral Training Programme, and joint research collaborations including with the Norfolk and Norwich University Hospital on prostate cancer and other studies.
  • COVID-19 Genomics UK (COG-UK) ConsortiumcoreStrategic or Co-development PartnerLed by the Wellcome Sanger Institute, this national consortium brings together NHS organisations, four Public Health Agencies, Wellcome Sanger Institute and 16+ academic institutions including Quadram Institute providing sequencing and analysis capacity for pathogen genomics.
  • Norwich Research Park PartnerscoreStrategic or Co-development PartnerPartnership with John Innes Centre, Earlham Institute, and other bioscience organizations on the Norwich Research Park enabling shared infrastructure, NMR facilities, and interdisciplinary research collaboration.
  • Earlham InstitutecoreStrategic or Co-development PartnerCollaborative research on gut microbiome, microbial interactions, and bioinformatics. Prof. Falk Hildebrand holds a joint position. Shared NMR resources available at John Innes Centre and UEA.
  • Imperial College LondonsecondaryStrategic or Co-development PartnerAcademic partner in the Food, Microbiome and Health research program focusing on food and gut microbiome research.
  • University of SurreysecondaryStrategic or Co-development PartnerAcademic partner in the Food, Microbiome and Health research program.
  • National Health Service (NHS)coreStrategic or Co-development PartnerPartnership with NHS through Norfolk and Norwich University Hospital for clinical research and patient care innovation. NIHR Clinical Research Facility provides infrastructure.
  • UK Health Security AgencycoreStrategic or Co-development PartnerKey strategic partner in public health research, food safety, and infectious disease surveillance through COG-UK consortium.
  • SKAN Research TrustsecondaryStrategic or Co-development PartnerCollaboration with SKAN Research Trust (India) in gut microbiome research to advance understanding of microbiome-related health conditions.
  • Jiangnan UniversitysecondaryStrategic or Co-development PartnerBBSRC-funded UK-China joint centre for research on probiotics. Prof. Arjan Narbad serves as Visiting Professor at Jiangnan University.
  • Wellcome Sanger InstitutecoreStrategic or Co-development PartnerLead institution of COG-UK consortium. Provides sequencing capacity and coordination for the national COVID-19 genomic surveillance effort.
  • Nature SeychellesminorStrategic or Co-development PartnerCollaboration on Seychelles warbler research studying gut bacteria and immune system interactions, alongside UEA, Centre for Microbial Interactions, and University of Groningen.
  • Cloud Infrastructure for Microbial Bioinformatics (CLIMB)coreTechnology or IntegrationCLIMB provides cloud computing infrastructure for microbial genomics, which was leveraged for COG-UK activities. Collaboration between Warwick, Birmingham, Cardiff, Swansea, Bath, Leicester, MRC Gambia, and Quadram Institute.
  • GLYTUNES Training NetworksecondaryStrategic or Co-development PartnerEuropean-funded multidisciplinary training network for bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis. Prof. Nathalie Juge participates in this initiative.
  • European Research Network Train2TargetsecondaryStrategic or Co-development PartnerEuropean Commission International Training Network funded by Horizon 2020 supporting research on Fusobacterium nucleatum and colorectal cancer.
  • XamplasecondaryStrategic or Co-development PartnerCollaboration to advance probiotic microencapsulation technology for improved delivery of beneficial bacteria.
  • Industry Advisory PanelsecondaryChannel Partner/ Reseller/ DistributorStructured engagement mechanism with industry partners providing guidance on research priorities and facilitating knowledge transfer from academia to commercial applications.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Quadram Institute competitors and assessment

Company assessment

Direct peers

  • Wellcome Sanger Institute: UK-based genomics and bioinformatics research institute that leads the COG-UK consortium in which Quadram participates. Operates at much larger scale but pursues overlapping pathogen genomics, microbiome, and translational biology programmes on a non-commercial, grant-funded basis.
  • John Innes Centre: Co-located on Norwich Research Park with Quadram; conducts plant science, microbiology, and food-related bioscience research. Directly comparable as a BBSRC-funded UK research institute with a similar funding mix and translational science mandate.
  • Earlham Institute: Co-located on Norwich Research Park; focused on computational bioscience, bioinformatics, and genomics. Several Quadram PIs (e.g. Falk Hildebrand) hold joint appointments, and the institute shares NMR and sequencing infrastructure with Quadram, making it a direct operating peer.
  • Rothamsted Research: Long-standing UK agricultural and food-safety research institute also funded by BBSRC. Comparable in operating model (publicly funded research, spinout track record) and overlapping research themes in food safety, crop science, and precision breeding, including the first gene-edited barley to receive a Precision Bred Organism marketing notice.
  • Babraham Institute: BBSRC-funded UK research institute focused on epigenetics, signalling, and immunology. Directly comparable in scale, funding mix, and biotech-spinout posture, and competes with Quadram for BBSRC strategic funding and life-science talent.
  • APC Microbiome Ireland: Ireland-based SFI-funded research centre focused on gut microbiome, host-microbe interactions, and microbial therapies. Closest international peer in terms of research focus (gut microbiome, microbially-produced bioactives, clinical translation), though funded through Irish research council mechanisms.

Broad incumbents

  • The Francis Crick Institute: Largest biomedical research institute in Europe, with overlapping interests in disease biology and translational medicine. Operates a similar model of public/charitable funding with deep clinical research partnerships, but at materially greater scale and broader scope than Quadram.
  • MRC Laboratory of Molecular Biology: MRC-funded research institute in Cambridge with a track record of basic biological discovery and successful spinouts. Comparable operating model (publicly funded research with strong IP translation) but a broader life-sciences remit and a longer-established entrepreneurial pipeline.
  • EMBL-EBI: European Bioinformatics Institute, part of EMBL. Comparable to Quadram's bioinformatics group (Hildebrand) in providing public-good computational infrastructure for genomics and microbiome data, including CLIMB compute used in COG-UK work that Quadram relies on.

Regional players

  • Teagasc: Ireland's national food and agriculture research authority, conducting food safety, microbiome, and agrifood research with similar translational and industry-facing remit to Quadram, but operating in a different national funding ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Quadram Institute social profiles

Digital presence

Quadram Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Quadram Institute leadership team

Management profile

Number of profiles

Quadram Institute funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Quadram Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quadram Institute

What does Quadram Institute do?

The Quadram Institute Bioscience (QIB) is an interdisciplinary research institute at Norwich Research Park that investigates how food and microbes interact to promote health. It delivers fundamental and applied bioscience research spanning gut microbiome science, food safety, and clinical nutrition, supported by next-generation sequencing services, advanced microscopy, organ-on-chip and gastrointestinal simulation platforms, and an integrated Clinical Research Facility operated with Norfolk and Norwich University Hospital.

Is Quadram Institute a public or private company?

Quadram Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Quadram Institute founded?

Quadram Institute was founded in 2017. It employs 101 to 250 people.

Where is Quadram Institute based?

Quadram Institute is headquartered in Norwich, United Kingdom, in the Europe region.

How does Quadram Institute make money?

Three revenue lines are on record. Research Grants and Public Funding is the primary driver. The others are fee-for-Service Sequencing and Research Services and enterprise Partnerships and Spinouts.

Who are Quadram Institute's main competitors?

Direct peers on record are Wellcome Sanger Institute, John Innes Centre, Earlham Institute, Rothamsted Research, Babraham Institute and APC Microbiome Ireland. Broad incumbents are The Francis Crick Institute, MRC Laboratory of Molecular Biology and EMBL-EBI. Teagasc is listed as a regional player.

Does Quadram Institute have an API?

No public API is recorded for Quadram Institute.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mirage NewsGiant Wheat Starch: Biotech Breakthrough for IndustryScientists at the John Innes Centre have developed wheat with super-sized starch granules (up to 50 micrometers, more than double the typical 20 micrometers) by engineering two cellular factors that limit starch granule growth. The biotechnological breakthrough creates larger starch storage space and reduces competition for growth substrates, resulting in unprecedented granule sizes in cereals. The research, conducted in collaboration with the Quadram Institute, demonstrates proof-of-concept for healthier, slower-digesting food products with potential benefits for human health and industrial applications including flour milling, paper making, pharmaceuticals, and cosmetics.Mirage NewsResearch Unveils Superbug SecretsResearchers at the University of East Anglia, in collaboration with the Quadram Institute and institutions in Canada and Mexico, analyzed 226 historical Acinetobacter baumannii samples dating from the 1970s to early 2000s to reconstruct the genetic evolution of this drug-resistant hospital superbug. The study found that the bacterium accumulated resistance gradually through successive waves of adaptation, becoming the dominant global lineage by around 2005 after acquiring key genetic elements including the oxa23 gene. The researchers identified four distinct evolutionary groups, with a fourth lineage now showing signs of rapid emergence and potentially greater antibiotic resistance.Food-safetyUK FSA Estimates Chicken Meat Causes More than 80 Percent of Human Campylobacteriosis CasesA UK-wide genomics study conducted by the UK Food Standards Agency in collaboration with University of Oxford, Moredun Institute, and Quadram Institute found increasing antimicrobial resistance in Campylobacter isolates from human infections, with fluoroquinolone resistance rising from 35.8% to 55.2% and tetracycline resistance from 32.6% to 48.2% between the previous study period and 2024. The research confirmed that chicken meat remains the dominant source of human campylobacteriosis, predicting that more than 80% of cases originate from chicken, while source attribution modeling estimated 86.7% and 79.7% of human C. jejuni and C. coli infections respectively come from chicken meat. Researchers concluded that incorporating whole genome sequencing and AI-based attribution frameworks into public health surveillance could support more targeted control measures across the food production chain.JicSalad packs a healthy punch to meet a growing Vitamin B12 needA partnership between the John Innes Centre, Quadram Institute, and LettUs Grow used aeroponics to grow pea shoots fortified with Vitamin B12, delivering over the recommended daily allowance in a 15-gram portion. The fortified shoots retained B12 through cold storage and were digestible, offering a low-cost plant-based source for B12 supplementation.The Cool DownResearchers make first-of-its-kind breakthrough that could change future of food: 'It offers huge potential'Scientists in the UK are testing gene-edited tomatoes that produce vitamin D when exposed to UV light, recruiting 76 participants with low vitamin D levels for the ViTaL-D Study. The trial aims to see if eating these tomatoes raises vitamin D levels as effectively as supplements. Researchers hope to bring the first 'sunshine tomato' to market within three years.BBCNorwich scientists explore link between dementia and gut microbesScientists at the Quadram Institute and Norfolk and Norwich University Hospital are studying gut microbes' role in dementia, with over 250 volunteers aged over 60. They aim to slow disease progression by altering diets or transplanting microbes, with funding from the BBSRC.PR NewswireSKAN Research Trust and Quadram Institute Bioscience to collaborate in Gut Microbiome ResearchSKAN Research Trust and UK-based Quadram Institute Bioscience have entered into a Comprehensive Partnership Agreement to collaborate on gut microbiome research focused on developing therapies for ageing and neurological diseases. The collaboration will involve joint research projects in both countries, technology transfer to enhance Indian research capabilities, and training of Indian research scientists, with their first project targeting microbiome-based therapies to alleviate symptoms of Parkinson's disease. The India leg of the research project will commence pending necessary approvals from the Government of India.PR NewswireEagle Genomics and Quadram Institute's New Strategic Partnership to Accelerate Microbiome Analysis Through AI-Augmented Knowledge Discovery PlatformEagle Genomics and the Quadram Institute announced a new strategic partnership to advance microbiome science by sharing datasets, innovation pipelines, and research tools through Eagle Genomics' AI-augmented e[datascientist]™ platform. The collaboration builds on Eagle Genomics' existing partnership with the Earlham Institute and aims to help scientists more efficiently interrogate multi-dimensional, multi-omic biological data related to microbiomes in humans, soil, plants, and animals. The partnership also references potential applications for meeting global nutritional requirements and reducing carbon footprints in food processing and agriculture sectors.PR NewswireFirst Automated System Using Fire Monkey HMW-DNA Extraction Installed at Quadram Institute for Pathogen Sequencing and AMR MonitoringRevoluGen Ltd., a UK genomics company, announced the installation of its first automated Fire Monkey high molecular weight DNA extraction system at Quadram Institute Biosciences for use across two bacterial sequencing projects focused on pathogen persistence and antimicrobial resistance monitoring. The system, which automates the extraction protocol into a 96-well filter plate format—the world's first automated extraction of library-ready HMW DNA—will process Salmonella and Campylobacter samples and is expected to lower overall sequencing costs while accelerating uptake in high-volume applications. The collaboration represents RevoluGen's first customer roll-out, with full commercial launch of the automated Fire Monkey HMW-DNA extraction kit anticipated in 2022.News-MedicalSupplements of Human Milk Oligosaccharides may help improve gut health in adultsA Quadram Institute study using gut-on-chip models found that fermented human milk oligosaccharides reduced gut lining permeability and increased tight-junction proteins. The findings suggest HMOs may help conditions linked to leaky gut, such as IBS, but human trials are needed.